Ncardia is an established, globally operating stem cell drug discovery & development company. At Ncardia we believe that stem technology will help to get better medicines to patients faster. The goal of the company is to be the supportive and trusted partner for scientists operating in the hiPSC drug discovery and development space, in particular for cardiovascular and neurological safety and efficacy studies.
Ncardia develops, produces and commercializes highly predictive human cardiovascular and neurological cellular assay systems for safety and efficacy testing. In addition, Ncardia develops and provides its customers with a broad portfolio of cardiovascular services from disease modeling to drug efficacy screening.
Not updated yet!
We are an enthusiastic, skilled and committed international team in which everyone has the opportunity to make a decisive contribution.
For more information, please visit our website www.ncardia.com.